Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, Böhmer FD, Gerke V, Schmidt-Arras DE, Berdel WE, Müller-Tidow C, Mann M, Serve H.
Mol Cell. 2009 Oct 23;36(2):326-39.PMID: 19854140 [PubMed - in process]Related articles